ImmunoGen, Inc. - Common Stock (NQ:IMGN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ImmunoGen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Minim (MINM) Stock Soars 77% After Receiving Nasdaq Deficiency Notice ↗

November 30, 2023

Minim stock is taking off with heavy trading of MINM shares on Thursday despite the company getting a delisting warning.

Via InvestorPlace

Why Is ImmunoGen (IMGN) Stock Up 81% Today? ↗

November 30, 2023

ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.

Via InvestorPlace

AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal ↗

November 30, 2023

IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere.

Via Investor's Business Daily

ImmunoGen Inc. (NASDAQ: IMGN) Near Top of Volume Charts in Thursday Trading

November 30, 2023

Via Investor Brand Network

La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday ↗

November 30, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

Via Benzinga

Topics Stocks

Health Care Company AbbVie Announces Acquisition of Immunogen ↗

November 30, 2023

Via Benzinga

Where Immunogen Stands With Analysts ↗

November 20, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Immunogen ↗

November 03, 2023

Via Benzinga

Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October ↗

November 30, 2023

U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the...

Via Benzinga

Topics Economy Stocks

IMGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ImmunoGen, Inc. Is Fair to Shareholders

November 30, 2023

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 30, 2023

Via Benzinga

These Three Biotech Stocks Are Trading At A Discount ↗

November 23, 2023

Investors exposed to the biotech sector have seen mixed results this year.

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 17, 2023

Via Benzinga

CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News ↗

November 17, 2023

CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.

Via Investor's Business Daily

Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating ↗

November 17, 2023

Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.

Via Investor's Business Daily

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 15, 2023

Via Benzinga

ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare Conference

November 02, 2023

From ImmunoGen, Inc.

Via Business Wire

ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results

November 02, 2023

From ImmunoGen Inc.

Via Business Wire

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 01, 2023

From ImmunoGen, Inc.,

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 27, 2023

Via Benzinga

ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

October 27, 2023

From ImmunoGen, Inc.

Via Business Wire

ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results

October 19, 2023

From ImmunoGen Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 11, 2023

Via Benzinga

Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside ↗

October 06, 2023

Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.

Via Benzinga

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 29, 2023

From ImmunoGen, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

ELAHERE® Shows Overall and Progression-Free Survival Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian Cancer

September 28, 2023

From ImmunoGen Inc.

Via Business Wire

On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

September 20, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress...

Via FinancialNewsMedia

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 18, 2023

From ImmunoGen, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.